Federal Register MedWatch Pharma News Warning Letters
IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM Injection 39.3%;19.6% HEXABRIX Mallinckrodt
For the most up-to-date approval information, please locate this API using the drug index.